Anthracycline-induced phospholipase A2 inhibition. 2007

Luther Swift, and Jane McHowat, and Narine Sarvazyan
Pharmacology and Physiology Department, The George Washington University, 2300 Eye Street, Washington, DC 20037, USA.

The purpose of this essay is to overview our findings that membrane-associated calcium-independent phospholipase A2 is markedly inhibited by low, clinically relevant concentrations of anthracyclines. Our studies suggest that due to the essential role of this enzyme in membrane homeostasis, its inhibition can be one of the early culprits leading to anthracycline-induced cardiac dysfunction. The clinical importance and potential pharmaceutical use of this new phenomenon await further studies.

UI MeSH Term Description Entries
D010741 Phospholipases A Phospholipases that hydrolyze one of the acyl groups of phosphoglycerides or glycerophosphatidates.
D010743 Phospholipids Lipids containing one or more phosphate groups, particularly those derived from either glycerol (phosphoglycerides see GLYCEROPHOSPHOLIPIDS) or sphingosine (SPHINGOLIPIDS). They are polar lipids that are of great importance for the structure and function of cell membranes and are the most abundant of membrane lipids, although not stored in large amounts in the system. Phosphatides,Phospholipid
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006331 Heart Diseases Pathological conditions involving the HEART including its structural and functional abnormalities. Cardiac Disorders,Heart Disorders,Cardiac Diseases,Cardiac Disease,Cardiac Disorder,Heart Disease,Heart Disorder
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000903 Antibiotics, Antineoplastic Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. Antineoplastic Antibiotics,Cytotoxic Antibiotics,Antibiotics, Cytotoxic
D054467 Phospholipases A2 Phospholipases that hydrolyze the acyl group attached to the 2-position of PHOSPHOGLYCERIDES. Lecithinase A2,Phospholipase A2

Related Publications

Luther Swift, and Jane McHowat, and Narine Sarvazyan
March 1997, The Journal of pharmacology and experimental therapeutics,
Luther Swift, and Jane McHowat, and Narine Sarvazyan
September 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology,
Luther Swift, and Jane McHowat, and Narine Sarvazyan
January 2021, Journal of lipid research,
Luther Swift, and Jane McHowat, and Narine Sarvazyan
February 1989, Klinische Wochenschrift,
Luther Swift, and Jane McHowat, and Narine Sarvazyan
January 1992, Eicosanoids,
Luther Swift, and Jane McHowat, and Narine Sarvazyan
October 1990, Biochimica et biophysica acta,
Luther Swift, and Jane McHowat, and Narine Sarvazyan
January 1999, Annual review of pharmacology and toxicology,
Luther Swift, and Jane McHowat, and Narine Sarvazyan
January 1991, Agents and actions,
Luther Swift, and Jane McHowat, and Narine Sarvazyan
March 1993, Trends in pharmacological sciences,
Luther Swift, and Jane McHowat, and Narine Sarvazyan
August 1992, Biochemical pharmacology,
Copied contents to your clipboard!